Steven Cohen Rocket Pharmaceuticals, Inc. Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,569,823 shares of RCKT stock, worth $11.9 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,569,823
Previous 48,096
3163.94%
Holding current value
$11.9 Million
Previous $888,000
2122.07%
% of portfolio
0.05%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RCKT
# of Institutions
242Shares Held
94.3MCall Options Held
262KPut Options Held
159K-
Rtw Investments, LP New York, NY17.7MShares$134 Million3.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$49.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$47 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$39.5 Million1.26% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.71MShares$35.8 Million0.27% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $574M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...